PartnershipApr 30, 2026, 07:21 PM
HELP Partners TARA Mind for HLP003 Phase 3 Recruitment & Veteran Outreach
AI Summary
Helus Pharma (HELP) announced a collaboration with TARA Mind to support clinical trial recruitment for its PARADIGM HLP003 Phase 3 program for Major Depressive Disorder. The partnership also aims to expand mental health awareness and access within the veteran community, aligning with a recent Executive Order on accelerating mental health treatments. HLP003 has FDA Breakthrough Therapy designation, and TARA Mind will utilize its networks to facilitate veteran engagement.
Key Highlights
- HELP partners TARA Mind for HLP003 Phase 3 MDD trial recruitment.
- Collaboration expands mental health awareness and access for veterans.
- Partnership aligns with April 18, 2026 Executive Order on mental health.
- HLP003 program holds FDA Breakthrough Therapy designation.
- TARA Mind to leverage networks for veteran engagement and recruitment.
- HELP also developing HLP004 in Phase 2 for generalized anxiety disorder.